Absolutely, it is a good sign. But the frustrating part is the delay after the first successful trial when the drug was formerly known as Neurodex, and the request for new "safety" data, wihich generated the more recent trials, etc. Zenvia will get to market, likely sometime in 2010, and will be a blockbuster drug for AVNR, which should lead to huge profits.
News 
Market Data 
Discover 
